Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01332006
What this trial is testing

Intra-bone Cord Blood Transplantation

Who this might be right for
Hematologic Neoplasms
Università degli Studi di Brescia 17
Testing effectiveness (Phase 2)Study completedNCT03712878
What this trial is testing

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 10
Early research (Phase 1)Ended earlyNCT02931110
What this trial is testing

Study of IV CBL0137 in Previously Treated Hematological Subjects

Who this might be right for
Hematological Malignancies
Incuron 5
Early research (Phase 1)Study completedNCT00824135
What this trial is testing

Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
St. Jude Children's Research Hospital 34
Early research (Phase 1)Study completedNCT00891592
What this trial is testing

Umbilical Cord Blood Transplant for Hematological Malignancies

Who this might be right for
CMLAMLMDS+4 more
University of Pennsylvania 5
Not applicableStudy completedNCT02343965
What this trial is testing

The Impact of the Practice of Touch-massage on the Anxiety of Patients With Hematological Disorders Hospitalized in a Protective Environment, a Randomized, Controlled Study

Who this might be right for
Hematologic Diseases
Nantes University Hospital 62
Testing effectiveness (Phase 2)UnknownNCT01757145
What this trial is testing

Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation

Who this might be right for
Hematological MalignancyBone Marrow Failure Syndrome
Rabin Medical Center 20
Not applicableStudy completedNCT00159003
What this trial is testing

Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia
Deborah Rund 100
Testing effectiveness (Phase 2)Ended earlyNCT03037645
What this trial is testing

Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLymphoplasmacytoid Lymphoma+5 more
Sunesis Pharmaceuticals 39
Post-approval studies (Phase 4)Study completedNCT07759674
What this trial is testing

Relationship Between Metformin Treatment, Anemia, and Erythropoietin Levels in Women With Polycystic Ovary Syndrome in Jordan

Who this might be right for
Polycystic Ovary Syndrome (PCOS) WomenInsulin Resistance Syndrome
Jerash Private University 25
Early research (Phase 1)Study completedNCT01830010
What this trial is testing

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

Who this might be right for
Hematological Malignancies
Novartis Pharmaceuticals 23
Not applicableActive Not RecruitingNCT05294991
What this trial is testing

Wellness App for Sleep Disturbance in Hematological Cancer Patients

Who this might be right for
CancerSleep DisturbanceAnxiety+3 more
The University of Texas Health Science Center at San Antonio 276
Testing effectiveness (Phase 2)Study completedNCT02106650
What this trial is testing

Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies

Who this might be right for
Relapsed Peripheral T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma
Acrotech Biopharma Inc. 36
Not applicableStudy completedNCT02859623
What this trial is testing

Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHematological Malignancies
Centre Hospitalier Universitaire de Besancon 86
Large-scale testing (Phase 3)Ended earlyNCT03870750
What this trial is testing

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmNon-Neoplastic Hematologic and Lymphocytic Disorder
Fred Hutchinson Cancer Center 458
Large-scale testing (Phase 3)Study completedNCT00557817
What this trial is testing

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Hematological Malignancies
University of Liege 125
Testing effectiveness (Phase 2)Study completedNCT05269940
What this trial is testing

Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies

Who this might be right for
Non Hodgkin LymphomaPeripheral T Cell LymphomaCLL/SLL
Nanjing Zenshine Pharmaceuticals 40
Testing effectiveness (Phase 2)UnknownNCT05768035
What this trial is testing

Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide

Who this might be right for
Hematological Malignancies
Smart Immune SAS 40
Testing effectiveness (Phase 2)Study completedNCT01527045
What this trial is testing

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Aggressive Non-Hodgkin LymphomaBlasts Under 5 Percent of Bone Marrow Nucleated CellsChronic Lymphocytic Leukemia+18 more
Fred Hutchinson Cancer Center 47
Not applicableLooking for participantsNCT06834412
What this trial is testing

A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging

Who this might be right for
Hematological Malignancies
Xijing Hospital 120
Next Page